Imagine a surgical robot that isn't a giant machine taking up a whole room, but a compact tool that can be moved around easily. It acts like a smart assistant that helps surgeons see better and move more precisely without needing huge cuts in the patient. It's like switching from a bulky desktop computer to a powerful, portable laptop for surgery.
Current surgical robots are too expensive, bulky, and complex, leading to an adoption rate below 40% in Europe. Hospitals struggle with the need for dedicated rooms and high costs per procedure.
A modular robotic platform consisting of Camera and Assistive robots that can be combined into an Operative Robot. It includes integrated lens cleaning and smoke evacuation systems.
If you are a hospital dealing with high costs and space constraints of traditional robotics — this project developed a compact, transportable robotic platform that does not require a dedicated operating room. This allows for a wider range of procedures in existing spaces.
If you are a distributor dealing with low adoption rates of robotics (below 40% in Europe) — this project developed a system with a competitive purchase price and flexible payment plans. This lowers the barrier to entry for smaller clinics.
If you are a clinic dealing with the need for both single-port and multi-port access — this project developed one robot that switches between both configurations. This eliminates the need to buy multiple different systems for different specialties.
The platform offers a competitive purchase price and a low cost per procedure through convenient purchase plans to increase patient access.
Yes, the robot is versatile and can be used for gastrointestinal, gynecology, and urology surgeries by switching between single and multi-port configurations.
Based on available project data, the technology is developed by Valuebiotech SRL, but specific licensing terms are not detailed.
It is designed for quick integration with a setup time of only 10 minutes and does not require a dedicated surgical room due to its compact size.
The project period runs from 2023-04-01 to 2025-09-30.
The project is led by a single Italian SME, Valuebiotech SRL, with a 100% industry ratio. This lean structure suggests a highly focused commercial drive and direct control over the intellectual property, avoiding the complexities of large academic consortia.
Contact Valuebiotech SRL in Italy for partnership or procurement inquiries.
Contact us to explore licensing or distribution opportunities for the M.I.L.A.N.O. platform.
